08:30 - 08:50
- 第一阶段:致辞
- Session I: Remarks
主持人 Moderator
- 冯岚, 中国医药创新促进会副会长
- FENG Lan, Vice President of PhIRDA
08:35 - 08:40
- 南京领导致辞
- Welcome Remarks by Official from Nanjing Municipal People’s Government
08:40 - 08:45
- 主办方致辞
- Welcome Remarks by the Hosts
- 徐凯, 成都诺恩生物科技有限公司董事长、首席科学家
- XU Kai, Chairman&Chief Scientific Officer,Chengdu Nuoen Biotechnology Co., Ltd.
08:45 - 08:50
- 主办方致辞
- Welcome Remarks by the Hosts
- 张抒扬, 中国医药创新促进会会长,北京协和医院院长
- ZHANG Shuyang, Chairman of PhIRDA, President of Peking Union Medical College Hospital
08:50 - 10:10
- 第二阶段:主旨报告
- Session II: Keynote Speeches
主持人 Moderator
- 梁健霖, 华卫恒源(北京)生物医药科技有限公司创始人&CEO
- LIANG Jianlin, CEO,Everlifebiomed Technology Co.,Ltd
08:50 - 09:20
- 主旨报告1
- Keynote Speech 1
- 创新药物研发国家科技重大专项的战略思考与实施路径
- Strategic Considerations and Implementation Pathways for the National Science and Technology Major Project for Innovative Drug R&D
- 田永吉, 首都医科大学附属北京天坛医院神外小儿病房副主任
- TIAN Yongji, Vice-director of Pediatric Neurosurgery,Beijing Tiantan Hosipital, Capital Medical University
09:20 - 09:50
- 主旨报告2
- Keynote Speech 2
- 病原体与大健康
- Pathogen and Public Health
- 沈于阗, 广州赛隽生物科技有限公司首席战略执行官
- SHEN Yutian, CEO,Cellgenes Co., Ltd.
09:50 - 10:10
- 主旨报告3
- Keynote Speech 3
- 全球变局下中国医药创新产业格局重塑中的新机遇
- New Opportunities in Reshaping the Structure of China's Pharmaceutical Innovation Industry under Global Changes
- 宋瑞霖, 中国医药创新促进会首席专家
- SONG Ruilin, Chief Expert of PhIRDA
10:10 - 12:00
- 第三阶段:专题讨论
- Session III: Panel Discussion
10:10 - 11:05
- 专题讨论1
- Panel 1
- 创十年,砥砺铸新章——从跟随式创新走向源头创新,从本土布局到全球突围
- A Decade of Innovation, Forging New Chapters
--From Follower to Forerunner in Innovation, From Domestic Footprint to Global Breakthrough
主持人 Moderator
- 胡泰山, 上海辐联医药科技有限公司高级副总裁,药物化学负责人
- HU Taishan, Senior Vice President, Head of Medicinal Chemistry of Full-Life Technologies
讨论嘉宾:
Panelist:
- 黄梓筠, 苏利文·克伦威尔律师事务所合伙人
- Gwen WONG, Partner, Sullivan & Cromwell LLP
- 胡智渊, 北京深智序元生物科技有限公司总经理
- HU Zhiyuan, CEO of Beijing Deep Intelligent Sequence Origin Biotechnology Co., Ltd.
- 何风志, 北康医疗投资总经理
- HE Fengzhi, General Manager of BK Healthcare Capital
- 孙建奇, 上海美杰医疗科技有限公司董事长
- SUN Jianqi, Chairman of Shanghai MAaGI Medical Technology Co., Ltd.
- 蒯锐, 清华大学副教授
- KUAI Rui, Associate Professor of Tsinghua University
- 曹丹, 南京浦光生物科技有限公司总经理
- CAO Dan, General Manager of Nanjing Poclight Biotechnology Co.,Ltd
11:05 - 12:00
- 专题讨论2
- Panel 2
- 投未来,翱翔拓新程——资本周期与产业变革交汇,大国博弈辨识产业先机
- Invest in the Future, Soaring to New Journeys
-- Capital Return meets Industrial Revolution, Seek Opportunities among Great Power Rivalry
主持人 Moderator
- 薛向东, 上海交通大学副教授
- XUE Xiangdong, Associate Professor of Shanghai Jiao Tong University
讨论嘉宾:
Panelist:
- 温淑娴, 信诺思健康科技有限公司首席运营官
- WEN Shuxian, Chief Operating Officer of Cinnotis Ltd
- 于常海, 香港生物科技协会主席
- Cheung-Hoi YU, Chairman of Hong Kong Biotechnology Organization
- 吴立宇, 上海立迪生物技术股份有限公司全球商务拓展副总裁
- WU Liyu, VP of Global BD, Shanghai LIDE Biotech, Co., Ltd.
- 马小伟, 苏州映辉医药科技有限公司融资总监
- MA Xiaowei, Director of Financing of Suzhou Infinory Pharmaceutical Technology Co., Ltd.
- 朱国广, 东吴证券研究所联席所长、大消费组组长、医药行业首席分析师
- ZHU Guoguang, Co-Director of the Institute, Leader of Consumer Sector Group, Chief Analyst for Healthcare Sector, Soochow Securities
- 邓婷, 赛诺菲全球注册事务大中华区注册事务负责人以及研发中国负责人
- DENG Ting, Head of GRA Greater China & RnD China Lead, Sanofi
- Ramy Younes, 勃林格殷格翰副总裁、全球心肾代谢领域临床开发负责人
- Ramy Younes, Corporate Vice President Global Head of Clinical Development CRM at Boehringer Ingelheim